Walgreens Health Services > Specialty Pharmacy > Limited-distribution drugs

Print

The following limited-distribution medications are available through Walgreens Specialty Pharmacy. (Manufacturers are listed in parentheses.)

Cimzia® (UCB, Inc.)
For reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy
More information at www.cimzia.com

H.P. Acthar® Gel (Questcor Pharmaceuticals, Inc.)
For the diagnostic testing of adrenocortical function, and for the treatment of acute exacerbations of multiple sclerosis
More information at www.acthar.com

Increlex™(Tercica, Inc.)
For the treatment of growth failure in children with severe primary IGF-1 deficiency (primary IGFD) or with growth hormone (GH) deletion who have developed neutralizing antibodies to GH
More information at www.increlex.com

Letairis™(Gilead Sciences, Inc.)
For the treatment of pulmonary arterial hypertension
More information at www.letairis.com

Macugen® ((OSI)™ Eyetech, Inc. and Pfizer, Inc.)
For the treatment of wet age-related macular degeneration
More information at www.macugen.com

Nexavar® (Bayer HealthCare AG)
For the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinoma
More information at www.nexavar.com

Raptiva® (Genentech, Inc.)
For the treatment of moderate to severe plaque psoriasis
More information at www.raptiva.com

Revlimid® (Celgene Corporation)
For the treatment of multiple myeloma and transfusion-dependent anemia due to deletion 5q myelodysplastic syndromes
More information at www.revlimid.com

Supprelin® LA (Indevus Pharmaceuticals, Inc.)
For the treatment of central precocious puberty
More information at www.indevus.com

Synagis® (MedImmune, Inc.)
For the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus
More information at www.synagis.com

Tykerb® (GlaxoSmithKline)
For the treatment of advanced or metastatic HER2-positive breast cancer
More information at www.tykerb.com

Tysabri® (Elan Pharmaceuticals, Inc.)
For the treatment of relapsing forms of multiple sclerosis and moderately to severely active Crohn’s disease
More information at www.tysabri.com

Visudyne® (Novartis Pharmaceuticials Corporation)
For the treatment of wet age-related macular degeneration, pathologic myopia, and presumed ocular histoplasmosis
More information at www.visudyne.com

Vivaglobin® (CSL Behring GmbH)
For the treatment of primary immune deficiency
More information at www.vivaglobin.com

Xolair® (Genentech, Inc. and Novartis Pharmaceuticals Corporation)
For the treatment of moderate to severe persistent allergic asthma
More information at www.xolair.com

Zorbtive® (EMD Serono, Inc.)
For the treatment of short bowel syndrome
More information at www.zorbtive.com